Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01858168
Title Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital

Ewing sarcoma


Olaparib + Temozolomide

Age Groups: adult
Covered Countries USA

No variant requirements are available.